A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid

详细信息    查看全文

• 作者：Masayuki Amagai^a ; ¹ ; ^{amagai@med.keio.ac.jp} ; Shigaku Ikeda^b ; ¹ ; Takashi Hashimoto^c ; Masato Mizuashi^d ; Akihiro Fujisawa^e ; ³ ; Hironobu Ihn^f ; Yasushi Matsuzaki^g ; Mikio Ohtsuka^h ; Hiroshi Fujiwaraⁱ ; ⁴ ; Junichi Furuta^j ; Osamu Tago^k ; ⁵ ; Jun Yamagami^a ; Akiko Tanikawa^a ; Hisashi Uhara^l ; Akimichi Morita^m ; Gen Nakanishiⁿ ; ⁶ ; Mamori Tani^o ; ⁷ ; Yumi Aoyama^p ; ⁸ ; Eiichi Makino^q ; ⁸ ; Masahiko Muto^r ; ⁹ ; Motomu Manabe^s ; Takayuki Konno^t ; Satoru Murata^u ; Seiichi Izaki^v ; ¹⁰ ; Hideaki Watanabe^w ; Yukie Yamaguchi^x ; Setsuko Matsukura^y ; ¹¹ ; Mariko Seishima^z ; Koji Habe^A ; Yuichi Yoshida^B ; Sakae Kaneko^C ; Hajime Shindo^D ; ¹² ; Kimiko Nakajima^E ; Takuro Kanekura^F ; Kenzo Takahashi^G ; Yasuo Kitajima^H ; Koji Hashimoto^I ; for the Bullous Pemphigoid Study Group²
• 关键词：ADR ; adverse drug reactions ; BPDAI ; bullous pemphigoid disease area index ; FAS ; full analysis-set ; IVIG ; intravenous immunoglobulin ; jBPAS ; japanese bullous pemphigoid activity score ; PDAI ; pemphigus disease area index
• 刊名：Journal of Dermatological Science
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：85
• 期：2
• 页码：77-84
• 全文大小：465 K
• 卷排序：85

文摘

IVIG is an effective treatment for pemphigus. IVIG has some therapeutic benefits for bullous pemphigoid, although the effect is not as dramatic as in pemphigus. IVIG provides a therapeutic option for steroid-resistant patients with bullous pemphigoid without immune suppression.